nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adoptive cell transfer immunotherapy for patients with solid epithelial cancers
|
Rosenberg, Steven A. |
|
|
41 |
4 |
p. 646-648 |
artikel |
2 |
A progressive T cell exhaustion program mapped across tissues in patients with lung cancer on immune checkpoint blockade
|
Mangana, Carolina |
|
|
41 |
4 |
p. 653-655 |
artikel |
3 |
BQ.1.1, XBB.1, and XBB.1.5 neutralization after bivalent mRNA COVID-19 booster in patients with cancer
|
Ehmsen, Sidse |
|
|
41 |
4 |
p. 649-650 |
artikel |
4 |
Challenges and opportunities for modeling aging and cancer
|
Anczuków, Olga |
|
|
41 |
4 |
p. 641-645 |
artikel |
5 |
ChemoNETosis: A road to tumor therapeutic resistance
|
Saw, Phei Er |
|
|
41 |
4 |
p. 655-657 |
artikel |
6 |
Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells
|
Park, Sun-Mi |
|
|
41 |
4 |
p. 726-739.e11 |
artikel |
7 |
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities
|
Sun, Claire Xin |
|
|
41 |
4 |
p. 660-677.e7 |
artikel |
8 |
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade
|
Pai, Joy A. |
|
|
41 |
4 |
p. 776-790.e7 |
artikel |
9 |
Mutations in IFN-γ signaling genes sensitize tumors to immune checkpoint blockade
|
Song, Eric |
|
|
41 |
4 |
p. 651-652 |
artikel |
10 |
Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma
|
Liu, Haofei |
|
|
41 |
4 |
p. 693-710.e8 |
artikel |
11 |
Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation
|
Mousset, Alexandra |
|
|
41 |
4 |
p. 757-775.e10 |
artikel |
12 |
Pre-cancer: From diagnosis to intervention opportunities
|
Hwang, E. Shelley |
|
|
41 |
4 |
p. 637-640 |
artikel |
13 |
Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma
|
Campbell, Katie M. |
|
|
41 |
4 |
p. 791-806.e4 |
artikel |
14 |
Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis
|
Zhou, Wei |
|
|
41 |
4 |
p. 740-756.e10 |
artikel |
15 |
T cell dynamism and immune-related adverse events
|
Johnson, Douglas B. |
|
|
41 |
4 |
p. 658-659 |
artikel |
16 |
T cell immune deficiency rather than chromosome instability predisposes patients with short telomere syndromes to squamous cancers
|
Schratz, Kristen E. |
|
|
41 |
4 |
p. 807-817.e6 |
artikel |
17 |
The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients
|
Friedrich, Mirco J. |
|
|
41 |
4 |
p. 711-725.e6 |
artikel |
18 |
Transcriptome analysis reveals tumor microenvironment changes in glioblastoma
|
Hoogstrate, Youri |
|
|
41 |
4 |
p. 678-692.e7 |
artikel |